GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: MK-7655 | MK-7655A | MK7655
                                 
                                                         
                            
                            
                            
                                 
                                
                                relebactam is an approved drug (FDA (2019), EMA (2020)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Relebactam is a β-lactamase inhibitor [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. EU EMA (2020) | US FDA (2019) | 
IUPAC Name ![]()  | 
                                                        
| [(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 10027 | relebactam | 
Synonyms ![]()  | 
                                                        
| MK-7655 | MK-7655A | MK7655 | 
Database Links ![]()  | 
                                                        |
| Specialist databases | |
                                                                        Antibiotic DB
                                                                        
                                                                              
                                                                        
                                                                             
                                                                     | 
                                                                    Relebactam | 
| Other databases | |
| CAS Registry No. | 1174018-99-5 (source: WHO INN record) | 
| ChEMBL Ligand | CHEMBL3112741 | 
| DrugBank Ligand | DB12377 | 
| DrugCentral Ligand | 5342 | 
| GtoPdb PubChem SID | 405560293 | 
| PubChem CID | 44129647 | 
| Search Google for chemical match using the InChIKey | SMOBCLHAZXOKDQ-ZJUUUORDSA-N | 
| Search Google for chemicals with the same backbone | SMOBCLHAZXOKDQ | 
| Search PubMed clinical trials | relebactam | 
| Search PubMed titles | relebactam | 
| Search PubMed titles/abstracts | relebactam | 
| UniChem Compound Search for chemical match using the InChIKey | SMOBCLHAZXOKDQ-ZJUUUORDSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | SMOBCLHAZXOKDQ-ZJUUUORDSA-N | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖| 
                                                                     
                                                                         
                                                                         
                                                                             
                                                                         
                                                                         
                                                                           
                                                                           Relebactam (links to external site) 
                                                                    
                                                                Cat. No. HY-16752  |